Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.

Author
Wei, Andrew H
Panayiotidis, Panayiotis
Montesinos, Pau
Laribi, Kamel
Ivanov, Vladimir
Kim, Inho
Novak, Jan
Champion, Rebecca
Fiedler, Walter
Pagoni, Maria
Publication date
2022-12-22
Subject
Haematology

Metadata
Show full item record
Abstract
No abstract available
Citation
Wei AH, Panayiotidis P, Montesinos P, Laribi K, Ivanov V, Kim I, Novak J, Champion R, Fiedler W, Pagoni M, Bergeron J, Ting SB, Hou JZ, Anagnostopoulos A, McDonald A, Murthy V, Yamauchi T, Wang J, Jiang Q, Sun Y, Chyla B, Mendes W, DiNardo CD. Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Blood. 2022 Dec 22;140(25):2754-2756. doi: 10.1182/blood.2022016963
Type
Article
Handle
http://hdl.handle.net/20.500.14200/2597
Additional Links
https://ashpublications.org/blood
https://www.sciencedirect.com/journal/blood
DOI
10.1182/blood.2022016963
PMID
36112968
Journal
Blood
Publisher
Elsevier
Collections